ATP11B and ovarian carcinoma: In contrast, another study reported that levels of ATP11B were decreased in ovarian cancer tissues [253], suggesting that cisplatin therapy may select for the cells expressing higher levels of ATP11B from a population of low-expressing cancer cells.